Nationwide trends in hospitalization, medical costs, and mortality for asthma after introduction of biologics: A cross-sectional study in the United States

BACKGROUND: Asthma is the most common inflammatory lung disease in the United States. Since 2015, biologic therapies have provided targeted treatment for patients with severe asthma. OBJECTIVE: To evaluate the trends for in-hospital outcomes of asthma before (2012-2014) and after (2016-2018) the int...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Hye-Rim, Hernandez-Con, Pilar, Heo, Ji Haeng, Wilson, Debbie L, Blake, Kathryn V, Lang, Jason E, Park, Haesuk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388017/
https://www.ncbi.nlm.nih.gov/pubmed/37404074
http://dx.doi.org/10.18553/jmcp.2023.29.7.721

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388017/
https://www.ncbi.nlm.nih.gov/pubmed/37404074
http://dx.doi.org/10.18553/jmcp.2023.29.7.721

Ejemplares similares